WallStreetZenWallStreetZen

NYSE: PFE
PFIZER INC Earnings & Revenue

Buy PFE
OverviewForecastEarnings
DividendOwnershipStatistics

PFE past earnings growth

How has PFE's earnings growth performed historically?
Company
132.46%
Industry
95.05%
Market
75.85%
PFE's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PFE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PFE's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PFE past revenue growth

How has PFE's revenue growth performed historically?
Company
100.43%
Industry
24.68%
Market
54.3%
PFE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PFE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PFE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PFE earnings and revenue history

Current Revenue
$92.4B
Current Earnings
$25.0B
Current Profit Margin
27%
PFE's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

PFE Return on Equity

Current Company
32.7%
Current Industry
42%
Current Market
38.4%
PFE's Return on Equity (32.7%)... subscribe to Premium to read more.
High Return on Equity Performance

PFE Return on Assets

Current Company
14%
Current Industry
10.4%
PFE is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PFE Return on Capital Employed

Current Company
18.8%
Current Industry
15.6%
PFE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PFE vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PFE$92.37B$32.34B$24.97B+11.92%+29.91%
LLY$29.32B$8.37B$6.13B+6.32%+26.58%
ABBV$56.73B$24.70B$12.48B+16.69%+12.44%
MRK$53.98B$19.42B$14.18B+6.21%+28.84%
AZN$41.49B$7.05B-$1.06B+13.23%N/A
View Top General Drug Manufacturer Stocks

PFE earnings dates

Next earnings date
Jul 26, 2022

PFIZER Earnings & Revenue FAQ

What were PFE's earnings last quarter?

On Invalid Date, PFIZER (NYSE: PFE) reported Q1 2022 earnings per share (EPS) of $1.40, up 60.92% year over year. Total PFIZER earnings for the quarter were $7.86 billion. In the same quarter last year, PFIZER's earnings per share (EPS) was $0.87.

What was PFE's earnings growth in the past year?

As of Q2 2022, PFIZER's earnings has grown 132.46% year over year. This is 37.41 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 95.05%. PFIZER's earnings in the past year totalled $24.97 billion.

What is PFE's earnings date?

PFIZER's earnings date is Invalid Date. Add PFE to your watchlist to be reminded of PFE's next earnings announcement.

What was PFE's revenue last quarter?

On Invalid Date, PFIZER (NYSE: PFE) reported Q1 2022 revenue of $25.66 billion up 76.78% year over year. In the same quarter last year, PFIZER's revenue was $14.52 billion.

What was PFE's revenue growth in the past year?

As of Q2 2022, PFIZER's revenue has grown 100.43% year over year. This is 75.75 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 24.68%. PFIZER's revenue in the past year totalled $92.37 billion.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.